The Global Tissue Engineering Market, by Material Type (Synthetic, Biological, and Others), by Application (Dermal, Orthopedic, Dental, Neurology, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 5.5 billion in 2017, and is projected to exhibit a CAGR of 11.5% over the forecast period (2018 - 2026).

Various diseases, injury, and trauma can lead to degeneration and damage of tissues in the human body, which necessitates treatments to enable repair, replacement or regeneration of damaged tissue. The treatment normally focuses on transplanting tissue from one site to another in the same patient (an autograft) or from one individual to another (a transplant or allograft). Tissue engineering is an inter-disciplinarily research area, which has wider applications in repair of organs, regeneration, and tissue transplantation. The technology uses synthetic or naturally derived, engineered biomaterials to replace defective or damaged tissues, such as bone, skin, and organs. Key manufacturers in the tissue engineering market are focused on mergers and acquisitions, and partnerships with smaller companies.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2217

For instance, in 2017, FUJIFILM Corporation invested US$ 3.7 million in the regenerative medicine venture company NC Medical Research, Inc. with NC Medical granting Fujifilm a stock allocation. Rapid advances in stem cell research with a focus on therapeutic potential for regenerative medicine and other biomedical applications are expected to drive market growth. In combination with tissue engineering, stem cells exhibit growth opportunities in further advancing modern medicine. Although much progress has been made in the field of tissue engineering, further research regarding organ and tissue replacement is necessary. The optimal cell source, scaffold design, and in vitro bioreactors, the use and development of microfabrication technology to create vascularized tissues and organs are still being investigated.

Browse 21 Market Data Tables and 24 Figures spread through 175 Pages and in-depth TOC on "Tissue Engineering Market, by Material Type (Synthetic, Biological and Others), by Application (Dermal, Orthopedic, Dental, Neurology, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/tissue-engineering-market-2217

Key Takeaways of the Tissue Engineering Market:

The global tissue engineering market is expected to expand at a CAGR of 11.5% during the forecast period (2018–2026), owing to increasing demand for organ transplantation.

Among region, Europe is expected to grow at lucrative rate, owing to presence of various public and private organizations focusing on research in tissue engineering field.

Major players operating in the global tissue engineering market include Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2217

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737